This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medco Tops Industry On Fortune's List Of 'World's Most Admired Companies' For Fifth Consecutive Year

FRANKLIN LAKES, N.J., March 1, 2012 /PRNewswire/ -- For the fifth consecutive year, Medco Health Solutions, Inc. (NYSE: MHS) has captured the No. 1 position within the Health Care: Pharmacy and Other Services sector on Fortune's "World's Most Admired Companies" list.  Medco earned the highest ranking across five of nine attributes within that sector: innovation, people management, social responsibility, quality of management, quality of products/services.  It earned the second highest ranking for the attributes: use of corporate assets, financial soundness, long-term investment and global competitiveness. 

(Logo: )

Medco is also ranked second among the most admired companies in New Jersey.

The Fortune World's Most Admired Companies list is a report card on corporate reputation. In partnership with the Hay Group, Fortune surveyed more than 698 companies across 58 industries and 32 countries. To establish the rankings, executives, directors, and securities analysts were asked to rate companies in their own industry on nine criteria, from investment value to social responsibility. Results will be featured in the March 5 issue of Fortune magazine.

"Medco employees are among the best and brightest in the healthcare industry, and their dedication to innovation and service have kept Medco a Most Admired company for 5 consecutive years," said Medco Chairman and CEO David B. Snow Jr. "To continue to earn this No. 1 position in our competitive sector demonstrates that Medco's business model and commitment to making medicine smarter is delivering value for our members, clients and shareholders."

About Medco Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy ® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately millions of Americans.  

With more than 20,000 employees worldwide dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2011 revenue of $70 billion, Medco ranks 34th on the 2011 Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. 

For more information, go to

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs